Eli Lilly Bets Big on Pennsylvania: $3.5 Billion Weight-Loss Drug Plant to Rise in Lehigh Valley
Pharmaceutical giant Eli Lilly is investing $3.5 billion to build a new manufacturing facility in rural Pennsylvania, marking its latest move in a massive U.S. expansion aimed at meeting soaring demand for next-generation obesity treatments and capitalizing on reshoring incentives.